Company / FCF Margin
Amylyx Pharmaceuticals, Inc. FCF Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-192.1%
FY2024
5-year range
-820.5% / 2.8%
FY2022-FY2024
Trend
-6959.3%
vs FY2023
Sector context
#98 of 134
Health Care
What the data says
FCF Margin changed -6959% YoY in FY2024, a notable deviation from the 2-year average annual change of -3429%.
Based on SEC 10-K filings.
-192.1% in FY2024.
Improved from -820.5% to -192.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#98 of 134 in Health CareTop 73% of 134This company -192.1% Sector average -637.8%
▼
+69.9% above sector average
Key checks
Key Insights
- In FY2024, fcf margin decreased 6959.3% year-over-year.
- Currently 445.7pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -192.1% | -6959.3% |
| FY2023 | 2.8% | +100.3% |
| FY2022 | -820.5% | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026